Scarica l'app Stockscreener
21.27
4.45%
-0.99
Dopo l'orario di chiusura:
21.32
0.05
+0.24%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$22.26
Aprire:
$22.23
Volume 24 ore:
635.67K
Relative Volume:
1.06
Capitalizzazione di mercato:
$1.07B
Reddito:
$290.38M
Utile/perdita netta:
$-21.03M
Rapporto P/E:
-49.53
EPS:
-0.4294
Flusso di cassa netto:
$-54.99M
1 W Prestazione:
-1.85%
1M Prestazione:
-5.09%
6M Prestazione:
-13.61%
1 anno Prestazione:
-12.32%
Intervallo 1D:
$21.06
$22.23
Intervallo di 1 settimana:
$21.06
$22.43
Portata 52W:
$15.59
$35.87
Staar Surgical Co Stock (STAA) Company Profile
Nome
Staar Surgical Co
Settore
Industria
Telefono
(626) 303-7902
Indirizzo
1911 WALKER AVE, MONROVIA, CA
Compare STAA vs ISRG, BDX, RMD, ALC, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
21.27 | 1.07B | 290.38M | -21.03M | -54.99M | -0.4294 |
ISRG
Intuitive Surgical Inc
|
426.70 | 150.74B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
191.75 | 52.23B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
238.97 | 33.61B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
66.18 | 31.99B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
35.96 | 31.55B | 29.14B | 1.07B | 1.05B | 1.1956 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-09-29 | Aggiornamento | Stifel | Hold → Buy |
| 2026-07-28 | Iniziato | UBS | Sell |
| 2026-05-14 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2026-04-09 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2026-02-03 | Iniziato | Wedbush | Neutral |
| 2026-01-16 | Ripresa | Morgan Stanley | Underweight |
| 2025-04-21 | Iniziato | Wells Fargo | Equal Weight |
| 2025-02-12 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-02-12 | Downgrade | Jefferies | Buy → Hold |
| 2025-02-12 | Downgrade | Mizuho | Outperform → Neutral |
| 2025-02-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-03-11 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-05 | Downgrade | Needham | Buy → Hold |
| 2023-12-04 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-09-15 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-08-03 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | Iniziato | Piper Sandler | Neutral |
| 2023-02-06 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-12-28 | Reiterato | BTIG Research | Buy |
| 2022-12-08 | Iniziato | Stifel | Hold |
| 2022-11-07 | Aggiornamento | Sidoti | Neutral → Buy |
| 2022-10-14 | Ripresa | Stephens | Overweight |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-04-08 | Iniziato | Needham | Buy |
| 2022-03-28 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2022-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2021-07-09 | Iniziato | Oppenheimer | Perform |
| 2021-01-19 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-10-26 | Downgrade | Sidoti | Buy → Neutral |
| 2020-08-31 | Aggiornamento | Sidoti | Neutral → Buy |
| 2020-08-06 | Reiterato | The Benchmark Company | Buy |
| 2020-07-06 | Downgrade | Sidoti | Buy → Neutral |
| 2020-06-24 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-06-15 | Iniziato | Jefferies | Buy |
| 2019-12-04 | Iniziato | BTIG Research | Buy |
| 2018-09-24 | Reiterato | The Benchmark Company | Buy |
| 2018-08-06 | Ripresa | The Benchmark Company | Buy |
| 2017-11-20 | Reiterato | The Benchmark Company | Buy |
| 2017-08-14 | Reiterato | The Benchmark Company | Buy |
| 2017-03-03 | Reiterato | The Benchmark Company | Buy |
| 2016-05-18 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2013-09-10 | Ripresa | The Benchmark Company | Buy |
| 2013-02-28 | Reiterato | The Benchmark Company | Buy |
| 2012-11-01 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | Iniziato | Northland Securities | Outperform |
| 2011-10-25 | Reiterato | The Benchmark Company | Buy |
| 2010-10-12 | Iniziato | Morgan Joseph | Buy |
| 2010-05-11 | Iniziato | Benchmark | Buy |
Mostra tutto
Staar Surgical Co Borsa (STAA) Ultime notizie
STAAR Surgical Company (STAA) Stock Forecasts - Yahoo! Finance Canada
STAAR Surgical Company (STAA) Stock Forecasts - Yahoo Finance
Midday Stock Roundup: Karman Slips - Orange County Business Journal
Has STAAR Surgical (STAA) Fallen Far Enough To Look Cheap? - Yahoo Finance
3 Reasons STAA is Risky and 1 Stock to Buy Instead - Yahoo Finance
STAAR Surgical Appoints Andrew Pilon, OD, as Vice President of Business Development - VisionMonday.com
STAAR Surgical names Andrew Pilon as VP of business development - Investing.com
A Johnson & Johnson Vision executive is joining STAAR Surgical to help build partnerships. - Stock Titan
Winners And Losers Of Q2: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The Medical Devices & SuppliesSpecialty Stocks - Yahoo Finance
STAAR Surgical Company (STAA) Stock Forecasts - Yahoo Finance
STAAR Surgical: A Recovery Story Priced As Growth - Seeking Alpha
STAAR Surgical Company (STAA) Stock Forecasts - Yahoo Finance
This Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - webull.com
Why Staar Surgical Zoomed Almost 8% Higher on Tuesday - The Motley Fool
Why Staar Surgical Zoomed Almost 8% Higher on Tuesday - AOL.com
Why Staar Surgical Zoomed Almost 8% Higher on Tuesday - The Motley Fool
A Look at Staar Surgical Co (STAA) After 7.5% Gain -- GF Value $33.25 vs Price $22.43 - GuruFocus
STAAR Surgical Analyst Turns Bullish On Potential For ‘Meaningful’ Street Upside - Benzinga
Why is STAAR Surgical stock surging today? - Investing.com
This Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
STAAR Surgical jumps on Stifel upgrade citing China growth potential - Investing.com
STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know - The Chronicle-Journal
STAA Upgraded by Stifel -- Price Target Raised to $31 - GuruFocus
STAAR Surgical jumps on Stifel upgrade citing China growth potential - Yahoo Finance
Stifel upgrades STAAR Surgical stock rating on China growth outlook - Investing.com
A Look at Staar Surgical Co (STAA) After 7.5% Gain -- GF Value $33.27 vs Price $20.51 - GuruFocus
Why Staar Surgical Stock Soared Today - The Motley Fool
STAA Looks 38.4% Undervalued on GF Value™ Despite Profit Challen - GuruFocus
STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know - Yahoo Finance
STAAR Surgical stock ticks higher on $50M buyback authorization - Investing.com
Why is STAAR Surgical stock climbing today? - Investing.com
STAAR Surgical authorizes $50 million share buyback program - Investing.com
STAAR Surgical Company (STAA) Stock forecasts - Yahoo Finance Singapore
STAAR Surgical stock ticks higher on $50M buyback authorization - Yahoo Finance
Is Staar Surgical Co (STAA) a Bargain After 4.1% Drop? GF Value Says Undervalued - GuruFocus
STAAR Surgical Company (STAA) Stock Forecasts - Yahoo Finance
STAAR Surgical Company (STAA) Stock Price, News, Quote & History - Yahoo! Finance Canada
STAA Rated Buy by Jefferies -- Price Target Lowered to $23 - GuruFocus
A Look at Staar Surgical Co (STAA) After 5.2% Decline -- GF Value $33.38 vs Price $21.24 - GuruFocus
STAAR Surgical (STAA) Swings To Profit On China Rebound - Yahoo Finance
STAAR Surgical (STAA) Says Implantable Lenses Are Taking Share From Laser Surgery - simplywall.st
Staar Surgical Co (STAA) Shares Fall 3.4% -- What GF Score of 81 Tells Investors - GuruFocus
STAAR Surgical hires former CEO to lead commercial team - MedTech Dive
STAAR Surgical Names David Bailey as Chief Commercial Officer with Detailed Compensation Package - Kalkine Media
STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer - Minichart
STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction - Finviz
U.S. laser procedures fell 52% as use of implantable lenses rose 76% - Stock Titan
STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction - Yahoo Finance
STAA Looks 29.6% Undervalued on GF Value™ - GuruFocus
Ex-STAAR Surgical CEO David Bailey Rejoins as Chief Commercial Officer - Medical Product Outsourcing
Staar Surgical Co Azioni (STAA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Staar Surgical Co Azioni (STAA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Michna Magda | Chief Development Officer |
Aug 14 '26 |
Option Exercise |
4.36 |
6,599 |
28,798 |
43,599 |
| Foust Warren | President and CEO |
Aug 14 '26 |
Option Exercise |
0.00 |
10,997 |
0 |
93,951 |
| Jiang Wei | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
10,683 |
0 |
77,127 |
| Butcher Arthur C | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
5,341 |
0 |
9,549 |
| SILVERMAN LOU | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
10,683 |
0 |
11,158 |
| Foust Warren | Interim Co-CEO and Pres. & COO |
Mar 14 '26 |
Option Exercise |
0.00 |
29,325 |
0 |
63,588 |
| Michna Magda | Chief Development Officer |
Mar 14 '26 |
Option Exercise |
0.00 |
17,595 |
0 |
36,001 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 13 '26 |
Buy |
18.61 |
316,017 |
5,882,656 |
16,123,842 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 12 '26 |
Buy |
18.12 |
299,432 |
5,424,330 |
15,807,825 |
| Foust Warren | Interim Co-CEO and Pres. & COO |
Mar 12 '26 |
Option Exercise |
0.00 |
8,175 |
0 |
34,263 |
6.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):